Jerard Seghatchian

InstitutionInternational Consultancy in Blood Components Quality/Safety Improvement
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 3 publications in Spetember 2020
    All Publications
    Bar chart showing 259 publications over 25 distinct years, with a maximum of 33 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Seghatchian J. Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount. Transfus Apher Sci. 2021 04; 60(2):103091. PMID: 33663928.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    2. Seghatchian J. WITHDRAWN: New Generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic. Transfus Apher Sci. 2021 Jan 11; 103064. PMID: 33518428.
      Citations:    Fields:    
    3. Seghatchian J. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic. Transfus Apher Sci. 2021 02; 60(1):103051. PMID: 33461918.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Lanza F, Seghatchian J. Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity. Transfus Apher Sci. 2020 Oct; 59(5):102941. PMID: 32958397.
      Citations:    Fields:    Translation:HumansCells
    5. Putter JS, Seghatchian J. An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research. Transfus Apher Sci. 2020 Oct; 59(5):102934. PMID: 32948465.
      Citations: 2     Fields:    Translation:Humans
    6. Seghatchian J, Acker JP, Putter JS. Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!! Transfus Apher Sci. 2020 Oct; 59(5):102933. PMID: 32919879.
      Citations:    Fields:    Translation:Humans
    7. Lanza F, Seghatchian J. Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients. Br J Haematol. 2020 Jul; 190(1):e27-e29. PMID: 32407543.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    8. Amiral J, Vissac AM, Seghatchian J. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? Transfus Apher Sci. 2020 Jun; 59(3):102804. PMID: 32387238.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    9. Seghatchian J, Lanza F. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci. 2020 06; 59(3):102794. PMID: 32448638.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    10. Seghatchian J, Lanza F. WITHDRAWN: Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike. Transfus Apher Sci. 2020 Apr 22; 102792. PMID: 32417123.
      Citations: 2     Fields: